Evidence map›Paper›PMID 33336840›Full record

ArticleGenes, chromosomes & cancer2021

Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions.

Liselot M Mus, Stéphane Van Haver, Mina Popovic, Wim Trypsteen, Steve Lefever, Nadja Zeltner, Yudelca Ogando, Eva Z Jacobs, Geertrui Denecker, Ellen Sanders and 14 more

Abstract read
In one paragraph

Article in Genes, chromosomes & cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. DPPA5A suppresses the mutagenic TLS and MMEJ pathways by modulating the cryptic splicing ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 5 institutions in 2 countries.

Liselot M MusDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.ORCID 0000-0001-5738-0639
Stéphane Van HaverDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Mina PopovicGhent-Fertility and Stem Cell Team (G-FaST), Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.
Wim TrypsteenDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Steve LefeverDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Nadja ZeltnerCenter for Molecular Medicine, Department of Biochemistry & Molecular Biology and Department of Cellular Biology, University of Georgia, Athens, Georgia, USA.
Yudelca OgandoDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA.
Eva Z JacobsDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Geertrui DeneckerDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Ellen SandersDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Christophe Van NesteDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Suzanne VanhauwaertDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.ORCID 0000-0002-7768-4549
Bieke DecaestekerDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Dieter DeforceGhent University, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Filip Van NieuwerburghGhent University, Cancer Research Institute Ghent (CRIG), Ghent, Belgium.
Pieter MestdaghDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Jo VandesompeleDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Björn MentenDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Katleen De PreterDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Lorenz StuderThe Center for Stem Cell Biology, Sloan Kettering Institute, New York, USA.
Björn HeindryckxGhent-Fertility and Stem Cell Team (G-FaST), Department for Reproductive Medicine, Ghent University Hospital, Ghent, Belgium.
Kaat DurinckDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Stephen RobertsDepartment of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, USA.
Frank SpelemanDepartment of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Ghent University · BEGhent University Hospital · BEMemorial Sloan Kettering Cancer Center · USKettering University · USUniversity of Georgia · US

Funding

Precision Medicine for the Peripheral Nervous System Disorder Familiar DysautonomiaR01NS114567 · NINDS · UNIVERSITY OF GEORGIA · PI Nadja Zeltner · 2021 to 2026
$3.0M
NINDS NIH HHS R01 NS114567
6 · The paper itself

Abstract

Human embryonic stem cells (hESCs) and embryonal tumors share a number of common features, including a compromised G1/S checkpoint. Consequently, these rapidly dividing hESCs and cancer cells undergo elevated levels of replicative stress, inducing genomic instability that drives chromosomal imbalances. In this context, it is of interest that long-term in vitro cultured hESCs exhibit a remarkable high incidence of segmental DNA copy number gains, some of which are also highly recurrent in certain malignancies such as 17q gain (17q+). The selective advantage of DNA copy number changes in these cells has been attributed to several underlying processes including enhanced proliferation. We hypothesized that these recurrent chromosomal imbalances become rapidly embedded in the cultured hESCs through a replicative stress driven Darwinian selection process. To this end, we compared the effect of hydroxyurea-induced replicative stress vs normal growth conditions in an equally mixed cell population of isogenic euploid and 17q + hESCs. We could show that 17q + hESCs rapidly overtook normal hESCs. Our data suggest that recurrent chromosomal segmental gains provide a proliferative advantage to hESCs under increased replicative stress, a process that may also explain the highly recurrent nature of certain imbalances in cancer.

Indexed as

Cell DivisionChromosome AberrationsSelection, GeneticCell CycleCell Line, TumorCell ProliferationChromosomes, Human, Pair 17DNA Copy Number VariationsHuman Embryonic Stem CellsHumansHydroxyureaStress, PhysiologicalTranscriptomeHydroxyureacopy number variationshESCreplicative stress

Identifiers

PMID33336840
PMCPMC11646134
OpenAlexW3111248719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.